Recursion to Present at Goldman Sachs Healthcare Conference
Event summary
- Recursion Pharmaceuticals (NASDAQ: RXRX) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
- The event will be webcast via the company's Investor Relations website.
- Recursion focuses on AI-driven drug discovery across oncology, rare diseases, neuroscience, and immunology.
The big picture
Recursion's participation in the Goldman Sachs conference underscores the increasing intersection of AI and biotech, as companies leverage advanced platforms to accelerate drug discovery. The event provides a platform for Recursion to showcase its differentiated approach in a competitive landscape, where scaling proprietary data and AI models is critical for success.
What we're watching
- Investor Sentiment
- How Recursion's presentation will impact investor confidence amid growing competition in AI-driven biotech.
- Pipeline Progress
- Whether the company will provide updates on its clinical-stage portfolio during the conference.
- Strategic Partnerships
- The pace at which Recursion expands collaborations to advance its TechBio platform.
Related topics